Status:

UNKNOWN

Exercise Timing and the Circadian Clock in Individuals With Type 2 Diabetes and Those at Risk

Lead Sponsor:

Faculdade de Motricidade Humana

Collaborating Sponsors:

Fundação para a Ciência e a Tecnologia

Conditions:

Diabetes Mellitus, Type 2

Eligibility:

All Genders

55-75 years

Phase:

NA

Brief Summary

Many investigations have been done to determine the exercise that can elicit the greatest benefits on glycemic control and metabolic health, with findings suggesting that incorporation of higher inten...

Detailed Description

To detect a predicted mean difference in 24-hour area under the curve (AUC) continuous glucose measure (CGM)-based glucose of 1.0 mmol/L with a within patient standard deviation (SD) of 0.85 mmol/L (2...

Eligibility Criteria

Inclusion

  • Inclusion Criteria (Group 1):
  • previous diagnosis of T2DM
  • currently taking metformin (Group 1 only);
  • Adults aged 55 to 75 years
  • Physically inactive people (i.e. with less than 20 minutes per day of exercise, maximum 3 days per week)
  • Exclusion Criteria (Group 1):
  • Use of exogenous insulin and taking any other antihyperglycemic medication beyond metformin
  • having major micro- or macro-vascular complications from T2DM
  • History of cardiovascular incidents
  • People with motor limitations (musculoskeletal or neurological) that limit the practice of physical exercise
  • inability to provide informed consent
  • Inclusion Criteria (Group 2):
  • BMI ≥25 without diagnosis of T2DM
  • Adults aged 55 to 75 years
  • Physically inactive people (i.e. with less than 20 minutes per day of exercise, maximum 3 days per week)
  • Exclusion Criteria (Group 2):
  • History of cardiovascular incidents
  • People with motor limitations (musculoskeletal or neurological) that limit the practice of physical exercise
  • inability to provide informed consent

Exclusion

    Key Trial Info

    Start Date :

    January 1 2024

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ESTIMATED

    End Date :

    December 1 2024

    Estimated Enrollment :

    34 Patients enrolled

    Trial Details

    Trial ID

    NCT06136013

    Start Date

    January 1 2024

    End Date

    December 1 2024

    Last Update

    November 18 2023

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Faculdade de Motricidade Humana

    Cruz Quebrada, Oeiras, Portugal, 1409-002